Has Mark Frankle, MD received payments from drug or device companies?

Yes. Drug and device makers reported $31,046,674 in general payments to Mark Frankle, MD across 1,064 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Frankle, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Frankle, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Frankle, MD

Orthopaedic Surgery · Temple Terrace, FLNPI 1780680074

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $28,589,502 of the $31,046,674 with a category attached, or 92.1%. Encore Medical, LP accounts for 99.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $7,333,021 and has fallen 63.3% since, to $2,693,778 in 2025. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,046,674in general payments, 2019–2025

Across 1,064 payments — averaging $29,179 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Encore Medical, LP$30.9M
Zimmer Biomet$119K
Insight Medical Systems, Inc.$13K
Limacorporate S.p.a.$3K
Stryker$422
Edwards Lifesciences$156
plus $329 from 7 others

$383,392in research payments, 2019–2025

Across 62 payments — averaging $6183.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Encore Medical, LP$350K
Zimmer Biomet$34K

What the payments were for

Royalty or licence$28,589,50292%
Consulting fees$2,369,0578%
Travel & lodging$76,0170%
Food & beverage$12,0980%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Encore Medical, LP	1,002	$30,910,554
Zimmer Biomet	33	$119,495
Insight Medical Systems, Inc.	3	$13,200
Limacorporate S.p.a.	3	$2,517
Stryker	12	$422
Edwards Lifesciences	1	$156
Smith+Nephew	3	$127
Biocomposites Inc	2	$65
Arthrex	1	$43
Acumed LLC	1	$33
Johnson & Johnson	1	$26
Medshape, Inc.	1	$22
Pacira Pharmaceuticals Incorporated	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DJO SURGICAL$44,306,061
DJO Surgical Turon Modular Shoulder System$10,455,641
DJO Surgical AltiVate Reverse$10,337,137
DJO Surgical AltiVate Anatomic System$680,966
Biowick$68,330
BioWick X$50,983
ARVIS$13,200
DJO Surgical Match Point System$13,144
SMR Shoulder system$2,400
SMR Shoulder$2,400
DJO Surgical Discovery Elbow System$2,034
DJO Surgical Empowr Knee System$680
DJO Surgical Alians Proximal Humerus Fracture Plate$595
DJO Surgical TaperFill Hip System$264

How this compares

$31,046,674 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$370,724

Medicare patients

640

Services billed

5,278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	56	$252
Methylprednisolone	21	$171
Doxycycline Hyclate	16	$142
Amoxicillin	23	$36
Clindamycin Hcl	18	$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Temple Terrace

Roy SandersTemple Terrace$19.6M
Thomas BernasekTemple Terrace$6.4M
Kenneth GustkeTemple Terrace$5.2M
Mark MighellTemple Terrace$4.3M
Michael GarciaTemple Terrace$1.1M
Christopher BakerTemple Terrace$575K
John SmallTemple Terrace$467K
Brian PalumboTemple Terrace$414K
Andrew CooperClearwater$102M
Richard HynesMelbourne$34.8M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →